Clinical and Translational Biomarkers

Discovery stages of clinical support and translational biomarkers are used to identify a compound’s impact on organs or tissues before the clinical effect have been Proved. It can be classified into three general classes: target biomarkers, mechanism biomarkers and disease biomarkers. Translational biomarker is based on whether it can be detectable, measurable and, in the end, it can be able to be qualified or validated.

 

  • Novel Biomarkers discovery
  • Clinical and analytical biomarker validation
  • Role of Biomarkers in clinical decision making
  • Application of Biomarkers in Drug discovery and development
  • Circulating Tumor DNA cells as Biomarkers: Case studies for various cancers
  • Non-invasive Biomarker for dug toxicity studies
  • Next-Generation Sequencing (NGS) assays for Translational and Clinical Research in Oncology
  • Biomarkers in Clinical trials: Design, strategies & application case studies

Related Conference of Clinical and Translational Biomarkers

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Clinical and Translational Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in